OncoSil Medical Ltd (AU:OSL) has released an update.
Meet Samuel – Your Personal Investing Prophet
- Start a conversation with TipRanks’ trusted, data-backed investment intelligence
- Ask Samuel about stocks, your portfolio, or the market and get instant, personalized insights in seconds
OncoSil Medical Limited is set to host an investor webinar to highlight recent milestones and strategic plans in commercializing its innovative cancer treatment device for pancreatic cancer. The company’s CEO, Nigel Lange, will discuss key achievements, including significant regulatory approvals, which position the OncoSil™ device as a leading treatment option in several global markets. Investors can gain insights into the company’s growth strategy and its potential impact on the MedTech industry.
For further insights into AU:OSL stock, check out TipRanks’ Stock Analysis page.